Vale S.A. (VALE) retained a “Sector Perform” rating from RBC Capital analyst Marina Calero on March 12, 2026, suggesting that the stock’s potential alignment with its pricing strategy could appeal to ...

Dow Inc. (DOW) has garnered renewed interest from investors following an uplifting call from Citigroup analyst Patrick Cunningham, who upgraded the stock to a “Buy” rating o. This endorsement comes ...

Conagra Brands, Inc. (CAG) is facing scrutiny after Wells Fargo analyst Chris Carey downgraded the stock to an “Underweight” rating from a previous hold on March 12, 2026. This rating adjustment comes ...

UiPath Inc. (NYSE: PATH) has garnered a bullish rating from analyst Scott Berg of Needham, who has placed a “Buy” designation on the stock as of. This recommendation comes with a price target of $15, ...

Nutrien Ltd. (NYSE: NTR) received a bullish “Buy” rating from analyst Laurence Alexander at Jefferies, a notable endorsement that suggests a potential upside of over 20% from its current price of $79.

In a significant analyst update, Generac Holdings Inc. (GNRC) has been downgraded to a Neutral rating by Vikram Bagri of Citigroup as of. The analyst sets a price target of $237 for the stock, ...

Telefônica Brasil S.A. (NYSE: VIV) has recently received an Equal-Weight rating from Mathieu Robilliard at Barclays, as of. This rating implies market analysts believe the company’s shares will ...

CVS Health Corporation (CVS) has recently garnered attention from analysts, receiving an “Outperform” rating from Lance Wilkes at Bernstein o. With a current stock price of $75.72 and a target price ...

In a notable shift that may impact investor sentiment, Wells Fargo analyst Sam Margolin upgraded Occidental Petroleum Corporation (OXY) to an “Overweight” rating o. This upgrade comes with a price ...

The Campbell Soup Company (CPB) has recently received a downgrade to “Underweight” from analyst Chris Carey at Wells Fargo, reflecting a bearish outlook on the stock’s potential in the near term. This ...

In a notable development for investors, Vtex (VTEX) has recently secured an “Outperform” rating from Daniel Federle of Banco Bradesco BBI S.A. o. This upgrade comes as the stock, currently priced at ...

In a significant move for Vera Therapeutics, Inc. (NASDAQ: VERA), analyst Andy Chen from Wolfe Research has initiated an “Outperform” rating as of. This upgrade comes with a notably ambitious price ...